ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

Red Wing seeks legal opinion, more info about mayor's frac sand involvement

c3b7a567635f1260ae691885dc94d2c1.jpg
Citizens packed Red Wing City Hall Monday night to hear discussion about Mayor Dennis Egan's (middle, dark hair) new role as executive director as for the Minnesota Industrial Sand Council. Some feel it's represents a conflict of interest and asked him to step down.
We are part of The Trust Project.

RED WING — An independent investigator will look through Red Wing Mayor Dennis Egan's business dealings at the request of the Red Wing City Council to determine if he has any conflict of interest between his role as the city's leader and his new job as executive director of the Minnesota Industrial Sand Council.

The council unanimously voted Monday night for the investigation. They also approved a request for a legal opinion from the Minnesota Attorney General on Egan's situation. The meeting attracted a crowd and one man was escorted out by police after an outburst.

Egan, a long-time lobbyist, was recently hired as executive director of the Minnesota Industrial Sand Council, a conglomeration of six private companies with interests in silica sand, gravel and related industries; the company proposing the new silica-related facilities in St. Charles is one of the six. Monday was the first time citizens and the council got to address Egan's decision publicly.

There is no conflict between the two positions, Egan said, and Red Wing City Attorney Jay Squires said that, legally speaking, he agrees.

"For me to pick and choose my livelihood (between) a client of mine and the mayor… I don't think that's a reasonable request," said Egan, who declined comment afterward.

ADVERTISEMENT

Council reaction

"I believe the mayor has to make a choice: Do you want to be the mayor of Red Wing or the executive director of the Minnesota Industrial Sand Council?" said Mike Schultz, a city council member.

Added council president Lisa Bayley: "I agree with the legal opinion that we don't have a legal conflict, but I think we have an inherent (ethical) conflict — a pretty massive inherent conflict."

Dale Hanson, a Red Wing resident, said he plans to initiate the recall process against Egan, who was re-elected to office in November. Hanson would need to gather 2,000 signatures from registered voters to initiate the action.

Egan said he will recuse himself from all discussions, votes and veto opportunities related to the silica sand industry. He got the chance to do so Monday as the city council unanimously approved a resolution asking the state to adopt strong permitting, a state-wide moratorium to allow study of the issue, such as a Generic Environmental Impact Statement for the silica industry.

Regional issue

Wabasha, Winona and St. Charles are among a number of local governmental bodies involved in seeking a compromise on silica sand mining and transporting that can both protect the public and allow the industry to bring jobs and business to the area.

The Minnesota Legislature is expected to take up the issue next week. The issue has thrust Egan into a heated public arena.

ADVERTISEMENT

"He's the leader of the city and now he's the leader of an organization that is lobbying for sand mining and I think … it makes us look corrupt and unprofessional in a lot of ways," said Amy Nelson, a representative of Save The Bluffs.

"That man is a corrupt man!" former Goodhue County Attorney Dick Johnson said of Egan before being escorted out by police.

What to read next
The award will support research on how colorectal cancer spreads to the liver.
Bebtelovimab is designed as a treatment option for those newly diagnosed with COVID-19 who cannot take Paxlovid and are deemed at high risk of severe outcomes. It replaces a series of monoclonal treatments that no longer are effective against virus due to mutation.
The largest U.S. home infusion pharmacy firm with locations in every state recently added Rochester Home Infusion to its team.
For decades, the drug industry has yelled bloody murder each time Congress considered a regulatory measure that threatened its profits. But the hyperbole reached a new pitch in recent weeks as the Senate moved to adopt modest drug pricing negotiation measures in the Inflation Reduction Act.